Skip to content

Clinical trials

Completed Adenocarcinoma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Status: Completed Country / region: Australia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20081
20092
20102
20141
20163
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Genzyme, a Sanofi Company2
Queensland Centre for Gynaecological Cancer2
Ariad Pharmaceuticals1
Australasian Gastro-Intestinal Trials Group1
Boehringer Ingelheim1
Celgene1
Checkpoint Therapeutics, Inc.1
Clovis Oncology, Inc.1
Sumitomo Pharma America, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma13
Neoplasms6
Carcinoma4
Carcinoma, Non-Small-Cell Lung4
Neoplasm Metastasis3
Carcinoma, Large Cell2
Carcinoma, Squamous Cell2
Digestive System Diseases2
Digestive System Neoplasms2
Endocrine Gland Neoplasms2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.